Digital Health Views & Analysis

Views & Analysis

Digital

Controlling AI hallucinations: Building evidence-based trust...

When it comes to GenAI, industry must demand evidence-grounded systems that prioritise verifiable clinical data and rigorous human oversight.

Digital

Changing Faces: Digital and supplier, March 2026

Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.

Digital

AI in clinical trials for protocol ingestion

From static documents to strategic capability: The case for ...

Protocol documentation will become protocol ingestion – an approach that’s automated, consistent, and intelligent.

Digital

Solution Spotlight: InsightBrain – AI-powered precision inte...

InsightBrain gives commercial leaders the signals and direction to deliver stronger launches, defend share, and stay ahead of the competition.

Digital

Fail fast is not a cultural problem. It is a capital allocat...

Even modest improvements in early predictive resolution can materially shift portfolio economics.

Digital

Trends outside the headlines, people reviewing graphs

Trends & Insights: February 2026 – A pharmaphorum industry r...

February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.

Controlling AI hallucinations: Building evidence-based trust...

Changing Faces: Digital and supplier, March 2026

From static documents to strategic capability: The case for ...

Solution Spotlight: InsightBrain – AI-powered precision inte...

Fail fast is not a cultural problem. It is a capital allocat...

Trends & Insights: February 2026 – A pharmaphorum industry r...

Enhertu OK ends 10-year EU gap in frontline breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks